Figure 2.
Figure 2. PFS and OS. (A) PFS from initiation of idelalisib in early PD patients. Kaplan-Meier curve showing PFS results in early-early PD (≤12 months) or late-early (12-24 months) FL patients treated with idelalisib. PFS (months) = (minimum [date of PD, date of death] − date of first dose of idelalisib + 1)/30.4375. (B) OS from initiation of idelalisib in early PD patients. The Kaplan-Meier survival curve shows the results of idelalisib treatment in early-early PD (≤12 months) or late-early (12-24 months) FL patients. OS (months) = (date of death − date of first dose of idelalisib +1)/30.4375. HR, hazard ratio.

PFS and OS. (A) PFS from initiation of idelalisib in early PD patients. Kaplan-Meier curve showing PFS results in early-early PD (≤12 months) or late-early (12-24 months) FL patients treated with idelalisib. PFS (months) = (minimum [date of PD, date of death] − date of first dose of idelalisib + 1)/30.4375. (B) OS from initiation of idelalisib in early PD patients. The Kaplan-Meier survival curve shows the results of idelalisib treatment in early-early PD (≤12 months) or late-early (12-24 months) FL patients. OS (months) = (date of death − date of first dose of idelalisib +1)/30.4375. HR, hazard ratio.

Close Modal

or Create an Account

Close Modal
Close Modal